Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation

Figure 3

(a) WBC count. (b) Hemoglobin. (c) Platelets. (d) LDH for the patient over time from date of presentation to current. The thick dashed line represents the time of imatinib administration while the thin dashed line represents the time of therapy conversion to sorafenib.

(a)

(b)

(c)

(d)